MEDP insider transaction filings
Medpace Holdings, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-21. Screen MEDP transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 20 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 23 legs across 16 filings by 7 insiders — 170,887 shares, $104,730,543 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 27,174 shares @ $618.79 ($16,814,999) by Troendle August J., filed 2026-08-21.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Troendle August J. — President & CEO, Director, 10% owner | 9 | — | 16 legs · 141,911 sh · $87,108,222 | — |
| BURWIG SUSAN E — Exec. VP, Operations | 2 | — | 1 leg · 7,500 sh · $4,500,000 | 2 |
| DAVENPORT FRED B JR — Director | 1 | — | 1 leg · 7,283 sh · $4,414,590 | 6 |
| Carley Brian T — Director | 2 | — | 1 leg · 5,000 sh · $3,043,150 | 2 |
| Kraft Robert O. — Director | 2 | — | 1 leg · 3,858 sh · $2,383,511 | 4 |
| Brady Kevin M. — CFO & Treasurer | 1 | — | 1 leg · 3,400 sh · $2,125,816 | 2 |
| McCarthy Cornelius P. III — Director | 3 | — | 2 legs · 1,935 sh · $1,155,253 | 4 |
Recent Form 4 filings — Medpace Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 10,880 @ $620.40 | EDGAR |
| 2026-09-17 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 15,971 @ $620.84 · Sale (S): 8,770 @ $621.29 | EDGAR |
| 2026-09-17 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 3,000 @ $166.73 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-08-31 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 650 @ $620.27 | EDGAR |
| 2026-08-28 | 4 | Kraft Robert O. — Director | Option exercise (M): 3,858 @ $84.36 · Sale (S): 3,858 @ $617.81 · Option exercise (M): 3,858 (derivative) @ $0 | EDGAR |
| 2026-08-27 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 673 @ $620.38 · Sale (S): 4,000 @ $620.03 | EDGAR |
| 2026-08-25 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 13,995 @ $624.45 · Sale (S): 1,983 @ $620.23 | EDGAR |
| 2026-08-24 | 4 | Brady Kevin M. — CFO & Treasurer | Option exercise (M): 3,400 @ $138.87 · Sale (S): 3,400 @ $625.24 · Option exercise (M): 3,400 (derivative) @ $0 | EDGAR |
| 2026-08-21 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 15,609 @ $606.47 · Sale (S): 27,174 @ $618.79 | EDGAR |
| 2026-08-21 | 4 | DAVENPORT FRED B JR — Director | Option exercise (M): 1,903 @ $133.87 · Option exercise (M): 3,858 @ $84.36 · Option exercise (M): 1,822 @ $164.68 · Sale (S): 7,283 @ $606.15 · Option exercise (M): 1,903 (derivative) @ $0 · Option exercise (M): 3,858 (derivative) @ $0 · +1 more | EDGAR |
| 2026-08-21 | 4 | Carley Brian T — Director | Sale (S): 5,000 @ $608.63 | EDGAR |
| 2026-08-14 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 11,366 @ $601.53 · Sale (S): 458 @ $600.39 | EDGAR |
| 2026-08-13 | 4 | McCarthy Cornelius P. III — Director | Sale (S): 1,140 @ $605.37 | EDGAR |
| 2026-08-12 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 5,534 @ $601.53 · Sale (S): 17,610 @ $605.11 | EDGAR |
| 2026-08-11 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 3,858 @ $84.36 · Sale (S): 795 @ $585.07 · Option exercise (M): 3,858 (derivative) @ $0 | EDGAR |
| 2026-07-29 | 4 | Troendle August J. — President & CEO, Director, 10% owner | Sale (S): 3,728 @ $600.85 · Sale (S): 3,510 @ $600.01 | EDGAR |
| 2026-07-29 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Sale (S): 7,500 @ $600 | EDGAR |
| 2026-07-02 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 28 · Option exercise (M): 28 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Carley Brian T — Director | Option exercise (M): 36 · Option exercise (M): 36 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Kraft Robert O. — Director | Option exercise (M): 33 · Option exercise (M): 33 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | EWALD STEPHEN P — General Counsel & Corp. Secy. | Option exercise (M): 16,349 @ $138.87 · Sale (S): 16,349 @ $450 · Option exercise (M): 16,349 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Zander Dani S. — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Gwadry-Sridhar Femida H. — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | McCarthy Cornelius P. III — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Carley Brian T — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Kraft Robert O. — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | DAVENPORT FRED B JR — Director | Grant/award (A): 1,110 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | Brady Kevin M. — CFO & Treasurer | Option exercise (M): 7,000 @ $138.87 · Option exercise (M): 7,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | EWALD STEPHEN P — General Counsel & Corp. Secy. | Option exercise (M): 3,500 @ $138.87 · Option exercise (M): 3,500 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | Troendle August J. — CEO, Director, 10% owner | Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 29 · Option exercise (M): 29 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Carley Brian T — Director | Option exercise (M): 36 · Option exercise (M): 36 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | Kraft Robert O. — Director | Option exercise (M): 33 · Option exercise (M): 33 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 12,000 @ $166.73 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | GEIGER JESSE J — President | Option exercise (M): 31,707 @ $138.87 · Sale (S): 31,707 @ $455.30 · Option exercise (M): 31,707 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | EWALD STEPHEN P — General Counsel & Corp. Secy. | Option exercise (M): 3,500 @ $138.87 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Carley Brian T — Director | Option exercise (M): 6,472 @ $54.99 · Option exercise (M): 6,472 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 10,984 @ $107.93 · Option exercise (M): 10,984 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | McCarthy Cornelius P. III — Director | Option exercise (M): 49 · Option exercise (M): 49 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Carley Brian T — Director | Option exercise (M): 62 · Option exercise (M): 62 (derivative) @ $0 | EDGAR |
| 2026-01-05 | 4 | Kraft Robert O. — Director | Option exercise (M): 56 · Option exercise (M): 56 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 10,000 @ $107.93 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | BURWIG SUSAN E — Exec. VP, Operations | Option exercise (M): 10,000 @ $107.93 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-04 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 668 @ $590.69 | EDGAR |
| 2025-12-03 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 23,178 @ $593.25 · Sale (S): 5,698 @ $590.47 | EDGAR |
| 2025-12-02 | 4 | McCarthy Cornelius P. III — Director | Grant/award (A): 113 (derivative) @ $592.46 | EDGAR |
| 2025-12-02 | 4 | Carley Brian T — Director | Grant/award (A): 143 (derivative) @ $592.46 | EDGAR |
| 2025-12-02 | 4 | Kraft Robert O. — Director | Grant/award (A): 130 (derivative) @ $592.46 | EDGAR |
| 2025-12-01 | 4 | Troendle August J. — CEO, Director, 10% owner | Sale (S): 41,331 @ $606.88 · Sale (S): 15,151 @ $593.46 | EDGAR |
Recent 8-K events — Medpace Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-19 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 2.02 — Results of Operations and Financial Condition 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-09 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MEDP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →